Advocacy intelligence hub — real-time data for patient organizations
Spevigo: FDA approved
treatment of generalized pustular psoriasis (GPP) in adults and pediatric patients 12 years of age and older and weighing at least 40 kg
Shanghai Huaota Biopharmaceutical Co., Ltd. — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance1
SPEVIGO
Boehringer Ingelheim
Spevigo
(spesolimab-sbzo)Orphan drugBoehringer Ingelheim Pharmaceuticals, Inc. (BI)
Interleukin-36 Receptor Antagonist [EPC]
12.1 Mechanism of Action Spesolimab-sbzo is a humanized monoclonal immunoglobulin G1 antibody that inhibits interleukin-36 (IL-36) signaling by specif...
Jianzhong Zhang, PhD, M.D
Peking University People's Hospital (PKUPH)
📍 HAMPTON, VA
Robert Bissonnette, MD
Innovaderm Research
Edward W Cowen, M.D., M.D
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
📍 SILVER SPRING, MD
Bristol Myers Squibb
Bristol-Myers Squibb
Robert Bissonnette, MD MSc FRCPC
Innovaderm Research Incorporated
Antonio Martorell, PhD
Hospital Universitari de Manises